Espumil, Lipophilic foam base, 500 ml, 24G15-T02-115604
Reported: November 5, 2025 Initiated: September 12, 2025 #D-0138-2026
Product Description
Espumil, Lipophilic foam base, 500 ml, 24G15-T02-115604
Reason for Recall
Labeling: Not Elsewhere Classified
Details
- Recalling Firm
- Letco Medical LLC
- Units Affected
- 173 500 ml bottles
- Distribution
- Product was distributed to: Letco Medical, LLC 1316 Commerce Drive Decatur, AL 35601 Product was further distributed to 44 compounding pharmacies and 2 distributors.
- Location
- Decatur, AL
Frequently Asked Questions
What product was recalled? ▼
Espumil, Lipophilic foam base, 500 ml, 24G15-T02-115604. Recalled by Letco Medical LLC. Units affected: 173 500 ml bottles.
Why was this product recalled? ▼
Labeling: Not Elsewhere Classified
Which agency issued this recall? ▼
This recall was issued by the FDA Drug on November 5, 2025. Severity: Low. Recall number: D-0138-2026.
Related Recalls
FDA Drug Moderate
Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only, Manufactured by: U…
Unichem Pharmaceuticals USA Inc. · 2026-02-11
FDA Drug Critical
Green Lumber Natural Fuel For Men capsule, packaged in 2, 4, 10, and 30-count blister packs. GreenLumber.com, 2618 San…
Green Lumber Holdings, LLC · 2026-02-11
FDA Drug Moderate
Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules India Limited, Hyderabad, 500…
Granules Pharmaceuticals Inc. · 2026-02-11
FDA Drug Critical
Diclofenac Sodium, Topical Gel, 3%, 100 g, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1…
SUN PHARMACEUTICAL INDUSTRIES INC · 2026-02-11
FDA Drug Critical
Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313
HANDELNINE GLOBAL LLC · 2026-02-11